Physician profile

John C Sciarra

Anesthesiology · Miami, FL

NPI 1326073867

$292.52

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$76.07

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Comsort, INC $100.00 2019
Mallinckrodt Enterprises LLC $47.98 2019
Mindray Ds USA, INC. $36.91 2023 Te X, Te7 Max
Karl Storz Endoscopy-America $34.92 2019
Smith+Nephew, INC. $25.06 2023 Renasys Go V2 Home, Pico 7, Renasys Touch
Bausch & Lomb, A Division of Bausch Health US, LLC $18.57 2019
Baudax Bio INC. $14.98 2022
Medline Industries Lp $14.10 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John C Sciarra

$292.52

in general payments reported 2019-2025

Years
2019-2023
Top company
Comsort, INC

https://glasscript.com/doctor/571532/john-c-sciarra

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.